COVID-19 vaccines and treatments have been an important tool in the prevention of COVID-19, including preventing hospitalizations and deaths.
Employer-Sponsored & Private Health Insurance
Reports
Displaying 1 - 10 of 26. 10 per page. Page 1.
Advanced SearchASPE Issue Brief
Marketplace Coverage and Economic Benefits: Key Issues and Evidence
July 20, 2022
This report highlights the impacts of the Affordable Care Act's Marketplace subsidies on coverage rates among self-employed adults and small business owners, based on tax data from the Department of Treasury and national survey data.
ASPE Issue Brief
Evidence on Surprise Billing: Protecting Consumers with the No Surprises Act
November 22, 2021
On January 1, 2022, the surprise billing provisions of the Consolidated Appropriations Act, 2021 - commonly referred to as the No Surprises Act - go into effect. Surprise billing occurs when a privately insured individual receives an unexpected bill either in an emergency situation or when a service in an in-network facility is provided by an out-of-network provider.
ASPE Issue Brief
Air Ambulance Use and Surprise Billing
September 10, 2021
Air ambulances are used to transport patients in critical situations from the scene of an injury or accident to hospitals, or between hospitals.
ASPE Issue Brief
Postpartum Opioid Prescription Fills, Opioid Use Disorder, and Utilization of Medication-Assisted Treatment among Women with Medicaid and Private Health Insurance Coverage Issue Brief
November 30, 2020
Postpartum Opioid Prescription Fills, Opioid Use Disorder, and Utilization of Medication-Assisted Treatment among Women with Medicaid and Private Health Insurance Coverage Issue Brief Mir M. Ali, Kristina West, and Emma Nye U.S. Department of Health and Human Services
Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report
February 26, 2019
ABSTRACT
Use of Medication-Assisted Treatment for Opioid Use Disorders in Employer-Sponsored Health Insurance: Out-of-Pocket Costs
February 11, 2019
This project assessed changes in opioid use disorder (OUD) treatment utilization and expenditures in the employer-sponsored private health insurance market during 2007 and 2014.
Use of Medication-Assisted Treatment for Opioid Use Disorders in Employer-Sponsored Health Insurance: Final Report
February 11, 2019
This project assessed changes in Opioid Use Disorder (OUD) treatment utilization and expenditures in the employer-sponsored private health insurance market at two timepoints, 2006-2007 and 2014-2015, that mark the periods before and after implementation of the Mental Health Parity and Addiction Equity Act (MHPAEA), the Affordable Care Act, the introduction and expanded use of new opioid treatme